Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8409861 Targeted deletion of cellular DNA sequences

Patent 8409861 was granted and assigned to Sangamo Biosciences Inc. on April, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 15, 2005
0
Date of Patent
April 2, 2013
0
Patent Application Number
11304981
0
Patent Citations Received
‌
US Patent 12129223 Lipids for use in lipid nanoparticle formulations
0
‌
US Patent 11690921 Delivery of target specific nucleases
0
‌
US Patent 11834686 Engineered target specific base editors
0
‌
US Patent 11857641 Method for the treatment of mucopolysaccharidosis type I
0
‌
US Patent 11920169 Compositions for linking DNA-binding domains and cleavage domains
0
‌
US Patent 11976019 Cationic lipids for use in lipid nanoparticles
0
‌
US Patent 11655275 Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
0
‌
US Patent 11661611 Genetic modification of cytokine inducible SH2-containing protein (CISH) gene
0
Patent Inventor Names
Dmitry Guschin
0
Michael C. Holmes
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8409861
0
Patent Primary Examiner
‌
Jennifer Dunston
0

Find more entities like US Patent 8409861 Targeted deletion of cellular DNA sequences

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.